ChemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial
Charlène J. van der Zijden(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Ben M. Eyck(Erasmus MC Cancer Institute), Joost J. Nuyttens(Erasmus MC Cancer Institute), Bas P. L. Wijnhoven(Inserm), Bianca Mostert(Erasmus MC), Ate van der Gaast(Erasmus MC), Leni van Doorn(Erasmus MC)
Cited by 14
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788